# Dina Turner

> Dina Turner, formerly known as Dina Radenkovic, is the Austin-based co-founder and CEO of Gameto. Born in Niš, Serbia, and educated at UCL, she worked in research and as a partner at SALT Bio Fund before co-founding Gameto in 2021 with Martin Varsavsky. Her career combines scientific training, venture investing and company operations; Gameto announced a $44 million Series C in August 2025.

- **Role:** Co-founder and Chief Executive Officer at Gameto
- **Organizations:** Gameto, SALT Bio Fund (former partner), Turner Venture Holdings, Hooke (co-founder and former scientific executive), University College London, King’s College London (former research post), Buck Institute for Research on Aging (former research post)
- **From:** Niš, Serbia
- **Nationality:** Serbian
- **Education:** Medicine (MBBS) and physiology; dual degree, University College London (UCL Medical School)
- **Known for:** F Factor runner-up at Founders Forum in 2015., UCL Meyerstein Scholarship and examination certificates of merit, documented on her LinkedIn profile., Forbes 30 Under 30, class of 2023.

## Career timeline

- **2015** — As a 20-year-old UCL student, became a runner-up in the F Factor technology competition at Founders Forum.
- **2019** — Completed UCL studies; subsequently worked at St Thomas’ Hospital and held research appointments.
- **2020** — Joined SALT Bio Fund as a partner in New York, while also working part-time at the Buck Institute, according to her 2025 interview.
- **2021** — Co-founded Gameto with Martin Varsavsky.
- **2023** — Included in the Forbes Under 30 class for 2023.
- **2024** — Led Gameto through an announced $33 million Series B.
- **2025** — Led Gameto through an announced $44 million Series C; named a BioSpace 40 Under 40 honoree.
- **2026** — Continues to lead Gameto; company announced a further Harvard intellectual property license in January.

## Achievements

- F Factor runner-up at Founders Forum in 2015.
- UCL Meyerstein Scholarship and examination certificates of merit, documented on her LinkedIn profile.
- Forbes 30 Under 30, class of 2023.
- BioSpace 40 Under 40, 2025.
- Gameto announced $117 million in venture funding plus a separate $10 million ARPA-H award.
- Gameto announced a $33 million Series B in May 2024 and a $44 million Series C in August 2025.

## Latest updates

- **2026-03** — Reshared Gameto’s public posts about its March 12 SXSW-week gathering in Austin on LinkedIn; this does not establish her attendance.
- **2026-01** — Gameto announced an additional Harvard intellectual property license on January 29.
- **2025-10** — Featured in BioSpace’s 2025 40 Under 40 recognition and an extended Inside Precision Medicine interview.
- **2025-08** — Gameto announced a $44 million Series C led by Overwater Ventures on August 12.

## Links

- Website: https://www.gametogen.com/
- LinkedIn: https://www.linkedin.com/in/dinaradenkovicturner
- Twitter/X: https://x.com/drdinaturner
- Instagram: https://www.instagram.com/dr_dinaradenkovic/

---

Profile page: https://yespress.io/dina-turner
Published by YesPress — https://yespress.io
Last updated: 2026-10-25